Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.3638
-0.0094 (-2.52%)
At close: Apr 28, 2025, 4:00 PM
0.3636
-0.0002 (-0.05%)
Pre-market: Apr 29, 2025, 8:04 AM EDT
Renovaro Market Cap
Renovaro has a market cap or net worth of $58.24 million as of April 29, 2025. Its market cap has decreased by -83.45% in one year.
Market Cap
58.24M
Enterprise Value
65.11M
1-Year Change
-83.45%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $58.24M, a decrease of -76.89%. That is a compound annual growth rate of -20.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 57.80M | -56.44% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |